Valuation: Teva Pharmaceutical Industries Limited

Market Cap 44.97B 40.97B 37.93B 34.31B 64.36B 4,200B 67.36B 458B 182B 2,270B 169B 165B 7,189B P/E 2026 *
115x
P/E 2027 * 21.1x
Enterprise Value 56.94B 51.88B 48.02B 43.44B 81.49B 5,318B 85.29B 580B 230B 2,874B 214B 209B 9,103B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.07x
Free-Float
91.3%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Limited

Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 70 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Sell

Director

-17 0.0000%
3/8/26 Exercice

Chief Technology Officer

131,066 0.0112%
3/8/26 Exercice

Head of Human Resources

38,481 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+2.01% - - 49.28B
-2.29%-5.34%+28.73%+128.34% 1,232B
-2.04%-5.78%+31.91%+78.34% 656B
-0.86%-3.71%+21.74%+105.02% 506B
-1.04%-1.80%+28.69%+68.01% 382B
-3.61%-9.62%+39.73%+30.53% 340B
-3.22%-5.20%+24.48%+51.30% 294B
-2.51%-4.49%-2.15%+29.67% 278B
-1.14%-6.05%+28.16%+65.35% 240B
-1.45%-0.85%+30.03%+120.72% 210B
Average -1.61%-2.30%+25.70%+75.25% 460B
Weighted average by Cap. -1.99%-2.67%+26.93%+87.80%

Financials

2026 *2027 *
Net sales 16.79B 15.3B 14.16B 12.81B 24.03B 1,568B 25.15B 171B 67.89B 847B 62.98B 61.66B 2,684B 17.35B 15.81B 14.63B 13.23B 24.83B 1,620B 25.99B 177B 70.16B 876B 65.09B 63.72B 2,773B
Net income 483M 440M 407M 368M 691M 45.08B 723M 4.92B 1.95B 24.36B 1.81B 1.77B 77.16B 2.2B 2B 1.85B 1.68B 3.15B 205B 3.29B 22.42B 8.89B 111B 8.25B 8.08B 352B
Net Debt 11.97B 10.91B 10.1B 9.13B 17.13B 1,118B 17.93B 122B 48.41B 604B 44.91B 43.97B 1,914B 8.36B 7.62B 7.05B 6.38B 11.97B 781B 12.53B 85.27B 33.82B 422B 31.38B 30.72B 1,337B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Trader
-
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Teva Pharmaceutical Industries Limited